 SOUTH SAN FRANCISCO, Calif., Oct. 11, 2022 GLOBE NEWSWIRE -- Akero Therapeutics, Inc. Nasdaq: AKRO, a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the H.C. Wainwright 6th Annual NASH Virtual Investor Conference on Monday, October 17, 2022, at 12:00 p.m. E.T. 